Home
About
Overview
Sharing Data
ORCID
Help
History (69)
Activity of crizotinib (PF02341066), a dual mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK) inhibitor, in a non-small cell lung cancer patient with de novo MET amplification.
Concurrent EGFR Mutation and ALK Translocation in Non-Small Cell Lung Cancer.
Patient-reported outcomes with durvalumab by PD-L1 expression and prior chemoradiotherapy-related variables in unresectable stage III non-small-cell lung cancer.
#SayHerName: Should Obstetrics and Gynecology Reckon with the Legacy of JM Sims?
Integration of artificial intelligence in lung cancer: Rise of the machine.
See All 69 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Integration of artificial intelligence in lung cancer: Rise of the machine.
Integration of artificial intelligence in lung cancer: Rise of the machine. Cell Rep Med. 2023 02 21; 4(2):100933.
View in:
PubMed
subject areas
Artificial Intelligence
Humans
Lung Neoplasms
Precision Medicine
Quality of Life
authors with profiles
Ravi Salgia